TYK2
6 drugs Immunology
5
approved indications
6
Approved Drugs
6
Companies
14
Indications
1
Therapeutic Areas
Top Drugs
Unlock Full Target Intelligence PRO
✓ Competitive landscape by company (6 companies)
✓ All 6 approved drugs
✓ Therapeutic area breakdown
✓ Full indication list (14 indications)
✓ Patent cliff analysis
✓ Clinical trials pipeline
Upgrade to Pro
Starting at $99/mo
Drugs by Company
PF PRISM CV 1 drug
Pfizer 1 drug
Eli Lilly 1 drug
By Therapeutic Area
Other 3 drugs
Immunology 3 drugs
By Therapeutic Area
Other 3 drugs
XELJANZ, ANZUPGO, LEQSELVI
Immunology 3 drugs
XELJANZ XR, OLUMIANT, SOTYKTU
Indications Treated
Moderately to severely active rheumatoid arthritisActive psoriatic arthritisActive ankylosing spondylitisModerately to severely active ulcerative colitisActive polyarticular course juvenile idiopathic arthritisChronic Hand EczemaRheumatoid ArthritisPsoriatic ArthritisAnkylosing SpondylitisUlcerative ColitisPolyarticular Juvenile Idiopathic ArthritisCOVID-19Alopecia AreataPlaque Psoriasis